2022
Efficacy and Safety of Cholinesterase Inhibitors in Alzheimer’s Disease: A Meta-analysis
Lane C, Conroy M. Efficacy and Safety of Cholinesterase Inhibitors in Alzheimer’s Disease: A Meta-analysis. 2022, 303-306. DOI: 10.1007/978-3-030-94960-0_53.Peer-Reviewed Original Research
2021
Behavioral Variant Frontotemporal Dementia: Diagnosis and Treatment Interventions
Balachandran S, Matlock E, Conroy M, Lane C. Behavioral Variant Frontotemporal Dementia: Diagnosis and Treatment Interventions. Current Geriatrics Reports 2021, 10: 101-107. DOI: 10.1007/s13670-021-00360-y.Peer-Reviewed Original ResearchVariant frontotemporal dementiaFrontotemporal dementiaCommon dementia syndromesCornerstone of treatmentNon-pharmacologic interventionsNon-pharmacologic managementCurrent pharmacologic therapiesBehavioral variant frontotemporal dementiaPrimary psychiatric illnessProgressive neurodegenerative disorderClinical research stagePharmacologic therapyDiagnostic workupDementia syndromesPsychiatric illnessTreatment interventionsCaregiver supportCholinesterase inhibitorsCertain symptomsReviewThe diagnosisBrain circuitsNeurodegenerative disordersEmotional bluntingDementiaBehavioral disinhibition